Well the good news is the stock rose immediately AFTER the bad news you mentioned. However, both articles were just stating facts that Q sucks in terms of sales growth. We need a partner for Q, and focus on the fast growing ED market instead of wasting resources, trying to fix a broken pipeline. Question is whether Q is marketable enough for a potential partner to take over?
First the good news. We are almost back to the level before the earnings results and traded the 2nd highest volume for 2015 (missed the honor by just 30K shares). There is no potential news events for the foreseeable future to drop the price back down (which has been the trend). Some momentum could develop if we cross $3 this time.
The bad news? We need record volumes for the year to just get back to where we were before earnings that produced 60% growth in Stendra sales and flat Q sales. Still trading 9% below cash while the markets are hitting all time highs.
I will take the positives for now - I am just down 15%! LOL...
Have they bought back any shares yet?
Have they given the promised dividend yet?
Have they sold a dime worth of products through the secretive global licensing agreement?
Have they gotten a dime worth of settlement from the "patent infringements"?
I wonder how these scams can operate for so long without being shut down. REVO and CRGP are wonderful examples of purest #$%$...
I meant the buyout, not the $4 prediction. Now can I get the thumbs down removed? LOL...
Heard that story before. It is total BS. To sell shares at 2 cents to their cronies when this was $2 after the RS says it all. They are still making over 100% by selling to the new gamblers falling for their new round of deceit. Record revenues and dividends my rear....
hiroller, I don't have to tell you about the past. But I am not going to get excited just by the share price movements but rather if we will have sales this time around. I think we will re-test 0.008 to a penny on release day but there is no guarantee we will get there or if it will stick this time if we do. That is totally dependent on revenues.
Just to clarify, I am here for the long run (2-3 years). I truly feel this will see the 30s again if management does their job. We definitely have the products to get there. My only and MAJOR complaint is - Although management "appears" to be doing things behind the scenes to make us successful down the road, they are doing diddly, nada, zilch to help shareholders today. They should be ashamed to let the stock trade below cash with such sure-shot products. I don't care if it is more or less than $50MM - that's not the point - but they need to announce a share buyback to show their faith in the business plan. That is the ONLY way to get the shorts scrambling and to get back to a respectable valuation - not institutional buying (like NTC and Blackrock), analyst upgrades (like RBC's $6 target) or good news like expanded insurance coverage or patents.
Looks like the move to a penny has begun. I thought of buying more at 0.0015 last week but held back due to past problems with the company's ability to sell this device. I sincerely hope this latest version will change all of that. The price is right and so is the design. The key is current and future software support for it, which will define the range of applications and hence the marketability of the product. But rest assured the upward trajectory will be maintained by my sales at every 0.001 increment! I have 14MM shares left....
Our car is sitting on the starting blocks for 6 months. Hope the ENDO pit crew is finishing the final touches to get us race ready. Time to release the horses!
And then it hit $10 in Mar 2002. You can also reminisce that it was $5.69 in Apr 95 and hit $37.50 in Aug 97. What about when it was $4 in Mar 2009 and hit $30 in May 2012? So, if you study history, it went up 7 fold in 2 years (95-97),up 5 fold in 1 year (2001-2002) and up 7 fold in 3 years (2009-2012). Thanks for reminding us that history will repeat again. But it will stick this time because it will be from real revenue growth from their FDA approved products.
pmt, I see your point on how many longs over here are happy with how management is running the show, without any regard for the stock price. Eye opening - that's for sure. Looks like I will take it upon me to keep pushing management. Better to try something new and fail than succeed in doing nothing...
maya, Seth is running a public company. So he is directly accountable to shareholders who own his company. This is not his backyard project to take his own time to hatch. If he wants to take this private - then sure he can take his time and be answerable only to the creditors. But since he took over, the stock is down 80%! He can continue to plot his scheme for long term domination but to completely ignore the stock price today (did he even mention that he is disappointed with the valuation once in the CC?) is downright irresponsible and grounds for termination. That is my only contention. I am not a buyer from $10 - so can wait. But there has to be a catalyst for shorts to cover and there isn't a better choice, unless they are not confident of their plans and need to hoard the money for their paychecks...
The time is right only after certain valuations are reached. When you are 10-15% below cash levels, that is when timing is everything. And institutions won't throw money in with the way management is communicating right now - no way. Many think Q is a lost cause. And they are not flippers either - they are long term investors. But management exactly knows where they really are and if they are confident of their plans, they must do this for the shareholders. You got to see my justification holistically. If this is a dying company, then what you say is true. If this is a growing company, this it makes all the sense in the world to do a share buyback (and raise money in the future). If they don't do it, then I would worry if they really know what they are doing, business wise. For someone who has 100K shares like me, I can't understand your logic, unless you are an insider who gets compensated in other ways. I really don't want to debate this topic. This is my last post on justifying my stand to you. You can have the last word if you wish.
PS: Even the discussion of a share buyback is getting this stock going today - LOL!
rup, keep the humor going. That's the only thing that will keep us going down here. BTW, are you short, long, or "no position - just here for banter" category? I never know on any given day...
Ok, let's just agree to disagree. I never said they can buy 20MM shares down here - not possible. It will be from here to $8 like you said (10-15MM shares) - which will keep the momentum going to said target. They continue doing whatever they are doing behind the scenes to make the gains stick (like growing sales). Of course, if they think there will be no progress made this year, then I agree they should be worried about institutions bailing and shorts coming back. But my plan will be welcomed by every shareholder, big or small, unless they love to sit below cash levels and hope that management will trump the shorts and analysts eventually. Can't believe we are actually arguing about this, being on the same side position wise. I have never heard about share buyback as a catalyst in the 6 months that I have been here. It is time to do something different to get different results, especially when trading below cash. Most probably it will not fly as management has not been shareholder friendly. But we should try. Better than arguing back and forth on a message board.
Chris, that's easy to explain.
1. The $10 target (which was just a suggestion) will be reached by the triple play of short covering, institutional adding and growing sales and income from Avanafil (and Q via partnership). That can be reached in 3-4 quarters.
2. The shelf offering is bought by investors, institutions etc. Obviously the story this year has to be good like partnerships, growing sales etc. No sticking it to the analysts to read between the lines.
3. NTC, Blackrock will buy (see 1) if they know that management is doing something shareholder friendly that will directly lead to a valuation adjustment. Right now, it is a shot in the dark as management is keeping everything close to their chest and not revealing much.
So, they have a new view of partnership which they didn't before? In other words, it is an 'absolute must' now rather than 'nice to have' before? OK, at least you got something new out of them.
I don't think they studied the share buyback strategy like I have laid it out. Shorts can't short it back down as the free float is almost gone now. They can only short a few million, even if that. The historical max has been 40MM shares. The very thought of 15-20MM shares being purchased systematically by the company is going to get them scrambling and institutions adding. And it is not to hold for several years either. They will get the money back and 3 times or more back when they sell into a secondary, which will also build a new base at $10. I am not going to leave this initiative easily. The ignorant need to be educated. LOL!
pmt, it takes less than 5 minutes to do what I did. Time much better spent than posting here. The past is history (the company had a $3B market cap and was smug), the future is a mystery. Live in the present, that's why it is called the "present". Just do it and then you can continue to complain on the board (which I am doing as well!).